Status:
COMPLETED
The Effect of GIP(3-30)NH2
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Collaborating Sponsors:
Steno Diabetes Center Copenhagen
University of Copenhagen
Conditions:
Endocrine - Other
Eligibility:
MALE
18-70 years
Phase:
NA
Brief Summary
Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor antagonist and evaluation of effect of insulin secretion in healthy subjects.
Detailed Description
Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor antagonist and evaluation of effect of insulin secretion in healthy subjects. Six study hyperglycemic clamps (10 mmol/l) pr. par...
Eligibility Criteria
Inclusion
- Healthy
- BMI 19-28 kg/m\*m
- Stable body weight
Exclusion
- Diabetes
- Anemia
- First-degree relatives with diabetes
Key Trial Info
Start Date :
December 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03770910
Start Date
December 6 2018
End Date
December 1 2019
Last Update
March 26 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Metabolic Physiology
Gentofte Municipality, Copenhagen, Denmark, 2900
2
Clinical Metabolic Physiology
Copenhagen, Gentofte, Denmark, 2900